QT Sense is a Groningen-based startup spun out from the University Medical Center Groningen (UMCG) in February 2024, leveraging nanodiamond-based quantum sensing to detect changes in cellular activity at the single-cell level. The company secured €6 million in funding to advance its quantum sensing technology for disease diagnostics. QT Sense’s flagship product, Quantum Nuova, is a single-cell Nano-MRI platform designed to measure cellular activity with high precision, enabling early sepsis diagnostics and personalized cancer treatment. The company’s quantum technology has the potential to detect sepsis within seconds, significantly improving survival rates. QT Sense’s technology can understand diseases at a single-cell level, revolutionizing medical diagnostics through quantum sensing.
Explore other quantum computing companies in similar categories or regions.
Information for Educational Purposes Only: All information about QT Sense is provided for informational and educational purposes only. This is not investment, financial, or professional advice.
No Warranties: While we strive for accuracy, Quantum Zeitgeist makes no warranties regarding the accuracy, completeness, or timeliness of company information. The quantum technology industry evolves rapidly, and information may become outdated.
No Endorsement: Inclusion in Quantum Navigator does not constitute an endorsement, recommendation, or verification of QT Sense's claims, technology, or business viability.
Do Your Own Research: Always conduct independent due diligence and consult qualified professionals (financial advisors, lawyers, etc.) before making investment, business, or career decisions.
For more information, see our Terms of Service and Privacy Policy.